Hong-Ying Jie1, Ji-Lu Ye1, Hai-Hua Zhou1, Yun-Xiang Li1. 1. Hong-Ying Jie, Ji-Lu Ye, Department of Intensive Care Unit, Taizhou People's Hospital, Medical School of Nantong University, Taizhou 225300, Jiangsu Province, China.
Abstract
AIM: To investigate the effect of perioperative restricted fluid therapy on circulating CD4(+)/CD8(+) T lymphocyte ratio, percentage of regulatory T cells (Treg) and postoperative complications in patients with colorectal cancer. METHODS: A total of 185 patients met the inclusion criteria and were included in the randomized clinical trial. These patients were divided into two groups according to receipt of either perioperative standard (S, n = 89) or restricted (R, n = 96) fluid therapy. Clinical data of these patients were collected in this prospective study. Perioperative complications and cellular immunity changes (CD4(+)/CD8(+) and Treg) were analyzed comparatively between the two groups. RESULTS: Both during surgery and on postoperative days, the total volumes of fluids administered in the R group were significantly lower than those in the S group (1620 ± 430 mL vs 3110 ± 840 mL; 2090 ± 360 mL vs 2750 ± 570 mL; 1750 ±260 mL vs 2740 ± 490 mL; 1620 ± 310 mL vs 2520 ± 300 mL; P < 0.05). Decreased ratios of circulating CD4(+)/CD8(+) T lymphocytes (1.47 ± 0.28 vs 2.13 ± 0.26; 1.39 ± 0.32 vs 2.21 ± 0.24; P < 0.05) and Treg percentage values (2.79 ± 1.24 vs 4.26 ± 1.04; 2.46 ± 0.98 vs 4.30 ± 1.12; P < 0.05) were observed after surgery in both groups. However, in the R group, these values restored more quickly starting from postoperative day 2 (1.44 ± 0.24 vs 1.34 ± 0.27; 2.93 ± 1.08 vs 2.52 ± 0.96; P < 0.05). The proportion of patients with complications was significantly lower in the restricted group (36 of 89 vs 59 of 96, P < 0.01). CONCLUSION: Perioperative restricted intravenous fluid regimen leads to a low postoperative complication rate and better cellular immunity preservation in patients with colorectal cancer.
RCT Entities:
AIM: To investigate the effect of perioperative restricted fluid therapy on circulating CD4(+)/CD8(+) T lymphocyte ratio, percentage of regulatory T cells (Treg) and postoperative complications in patients with colorectal cancer. METHODS: A total of 185 patients met the inclusion criteria and were included in the randomized clinical trial. These patients were divided into two groups according to receipt of either perioperative standard (S, n = 89) or restricted (R, n = 96) fluid therapy. Clinical data of these patients were collected in this prospective study. Perioperative complications and cellular immunity changes (CD4(+)/CD8(+) and Treg) were analyzed comparatively between the two groups. RESULTS: Both during surgery and on postoperative days, the total volumes of fluids administered in the R group were significantly lower than those in the S group (1620 ± 430 mL vs 3110 ± 840 mL; 2090 ± 360 mL vs 2750 ± 570 mL; 1750 ± 260 mL vs 2740 ± 490 mL; 1620 ± 310 mL vs 2520 ± 300 mL; P < 0.05). Decreased ratios of circulating CD4(+)/CD8(+) T lymphocytes (1.47 ± 0.28 vs 2.13 ± 0.26; 1.39 ± 0.32 vs 2.21 ± 0.24; P < 0.05) and Treg percentage values (2.79 ± 1.24 vs 4.26 ± 1.04; 2.46 ± 0.98 vs 4.30 ± 1.12; P < 0.05) were observed after surgery in both groups. However, in the R group, these values restored more quickly starting from postoperative day 2 (1.44 ± 0.24 vs 1.34 ± 0.27; 2.93 ± 1.08 vs 2.52 ± 0.96; P < 0.05). The proportion of patients with complications was significantly lower in the restricted group (36 of 89 vs 59 of 96, P < 0.01). CONCLUSION: Perioperative restricted intravenous fluid regimen leads to a low postoperative complication rate and better cellular immunity preservation in patients with colorectal cancer.
Authors: S J Warrillow; L Weinberg; F Parker; P Calzavacca; E Licari; A Aly; S Bagshaw; C Christophi; R Bellomo Journal: Anaesth Intensive Care Date: 2010-03 Impact factor: 1.669
Authors: Yu Wenkui; Li Ning; Gong Jianfeng; Li Weiqin; Tang Shaoqiu; Tong Zhihui; Gao Tao; Zhang Juanjuan; Xi Fengchan; Shi Hui; Zhu Weiming; Li Jie-Shou Journal: Surgery Date: 2009-12-11 Impact factor: 3.982
Authors: Nor'azim Mohd Yunos; Rinaldo Bellomo; Colin Hegarty; David Story; Lisa Ho; Michael Bailey Journal: JAMA Date: 2012-10-17 Impact factor: 56.272
Authors: C Finco; P Magnanini; G Sarzo; M Vecchiato; B Luongo; S Savastano; M Bortoliero; P Barison; S Merigliano Journal: Surg Endosc Date: 2007-03-14 Impact factor: 3.453
Authors: M von der Forst; S Weiterer; M Dietrich; M Loos; C Lichtenstern; M A Weigand; B H Siegler Journal: Anaesthesist Date: 2021-02 Impact factor: 1.041
Authors: Antonio Messina; Chiara Robba; Lorenzo Calabrò; Daniel Zambelli; Francesca Iannuzzi; Edoardo Molinari; Silvia Scarano; Denise Battaglini; Marta Baggiani; Giacomo De Mattei; Laura Saderi; Giovanni Sotgiu; Paolo Pelosi; Maurizio Cecconi Journal: Crit Care Date: 2021-06-11 Impact factor: 9.097
Authors: Corina Behrenbruch; Carolyn Shembrey; Sophie Paquet-Fifield; Christina Mølck; Hyun-Jung Cho; Michael Michael; Benjamin N J Thomson; Alexander G Heriot; Frédéric Hollande Journal: Clin Exp Metastasis Date: 2018-01-15 Impact factor: 4.510